PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $621,907 | -21.2% | 60,204 | 0.0% | 2.98% | -79.2% |
| Q2 2023 | $789,274 | +17.3% | 60,204 | 0.0% | 14.32% | +34.9% |
| Q1 2023 | $673,081 | +32.6% | 60,204 | 0.0% | 10.62% | +29.4% |
| Q4 2022 | $507,520 | -49.4% | 60,204 | 0.0% | 8.20% | +31.0% |
| Q3 2022 | $1,003,000 | +13.2% | 60,204 | 0.0% | 6.26% | +100.3% |
| Q2 2022 | $886,000 | -40.7% | 60,204 | 0.0% | 3.13% | -74.2% |
| Q1 2022 | $1,494,000 | -22.6% | 60,204 | 0.0% | 12.13% | -53.7% |
| Q4 2021 | $1,931,000 | -42.8% | 60,204 | -35.8% | 26.20% | +14.2% |
| Q3 2021 | $3,376,000 | -18.5% | 93,831 | 0.0% | 22.93% | +186.6% |
| Q2 2021 | $4,140,000 | -88.9% | 93,831 | -88.5% | 8.00% | -80.3% |
| Q1 2021 | $37,279,000 | -33.7% | 815,019 | 0.0% | 40.66% | -17.1% |
| Q4 2020 | $56,253,000 | – | 815,019 | – | 49.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |